Liu Q.,Collaborative Innovation Center for Chemistry and Molecular Medicine |
Liu Q.,CAS Beijing National Laboratory for Molecular |
Jin C.,Collaborative Innovation Center for Chemistry and Molecular Medicine |
Wang Y.,Molecular Genetics and Microbiology and Pathology and Laboratory Medicine |
And 5 more authors.
NPG Asia Materials | Year: 2014
Based on their unique advantages, increasing interest has been shown in the use of aptamers as target ligands for specific cancer cell recognition and targeted cancer therapy. Recently, the development of aptamer-conjugated nanomaterials has offered new therapeutic opportunities for cancer treatment with better efficacy and lower toxicity. We highlight some of the promising classes of aptamer-conjugated nanomaterials for the specific recognition of cancer cells and targeted cancer therapy. Recent developments in the use of novel strategies that enable sensitive and selective cancer cell recognition are introduced. In addition to targeted drug delivery for chemotherapy, we also review how aptamer-conjugated nanomaterials are being incorporated into emerging technologies with significant improvement in efficiency and selectivity in cancer treatment. © 2014 Nature Publishing Group.